Who manufactures Efluelda 0.7 ml, suspension injectable en seringue préremplie?

Sanofi-Aventis (Suisse) SA (CH)

OTC

Efluelda 0.7 ml, suspension injectable en seringue préremplie

INN: haemagglutininum influenzae A (H1N1) (Virus souche A/Victoria/4897/2022 (H1N1)-like: reassortant virus IVR-238 derived from A/Victoria/4897/2022)

Data updated: 2026-04-11

Tillgängligt i:

🇨🇿🇩🇪🇬🇧

Beredningsform

—

Dosering

—

Administreringsväg

—

Förvaring

—

User Reviews

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.